These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22140270)

  • 21. Regulation of immune responses by T cells.
    Jiang H; Chess L
    N Engl J Med; 2006 Mar; 354(11):1166-76. PubMed ID: 16540617
    [No Abstract]   [Full Text] [Related]  

  • 22. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?
    Lan Q; Fan H; Quesniaux V; Ryffel B; Liu Z; Zheng SG
    J Mol Cell Biol; 2012 Feb; 4(1):22-8. PubMed ID: 22107826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. World Immune Regulation Meeting (WIRM)--III: special focus on regulatory and effector mechanisms.
    Godoy L
    Drug News Perspect; 2009 Dec; 22(10):623-6. PubMed ID: 20140282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
    Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W
    Nature; 2007 Feb; 445(7128):648-51. PubMed ID: 17187052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on "Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice".
    Wolf D; Wolf AM; Tzankov A
    J Immunol; 2010 Apr; 184(8):4051. PubMed ID: 20368283
    [No Abstract]   [Full Text] [Related]  

  • 27. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.
    Mucida D; Park Y; Kim G; Turovskaya O; Scott I; Kronenberg M; Cheroutre H
    Science; 2007 Jul; 317(5835):256-60. PubMed ID: 17569825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
    J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoregulation during aging].
    Doria G
    Recenti Prog Med; 1988; 79(7-8):310-3. PubMed ID: 2974170
    [No Abstract]   [Full Text] [Related]  

  • 30. T(H)-17 cells in the circle of immunity and autoimmunity.
    Bettelli E; Oukka M; Kuchroo VK
    Nat Immunol; 2007 Apr; 8(4):345-50. PubMed ID: 17375096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β: the sword, the wand, and the shield of FOXP3(+) regulatory T cells.
    Tran DQ
    J Mol Cell Biol; 2012 Feb; 4(1):29-37. PubMed ID: 22158907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasticity of CD4+ T cell lineage differentiation.
    Zhou L; Chong MM; Littman DR
    Immunity; 2009 May; 30(5):646-55. PubMed ID: 19464987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empowering Regulatory T Cells in Autoimmunity.
    Kasper IR; Apostolidis SA; Sharabi A; Tsokos GC
    Trends Mol Med; 2016 Sep; 22(9):784-797. PubMed ID: 27461103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336.
    Fontenot JD; Gavin MA; Rudensky AY
    J Immunol; 2017 Feb; 198(3):986-992. PubMed ID: 28115587
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulatory T cells: promoting B cell responses to influenza virus.
    Kugelberg E
    Nat Rev Immunol; 2014 May; 14(5):283. PubMed ID: 24705704
    [No Abstract]   [Full Text] [Related]  

  • 36. Features and roles of T helper 22 cells in immunological diseases and malignancies.
    Hossein-Khannazer N; Zian Z; Bakkach J; Kamali AN; Hosseinzadeh R; Anka AU; Yazdani R; Azizi G
    Scand J Immunol; 2021 May; 93(5):e13030. PubMed ID: 33576072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3rd Keystone Symposium on T regulatory cells.
    McMurchy AN; Levings MK
    Immunotherapy; 2009 Jul; 1(4):529-37. PubMed ID: 20635985
    [No Abstract]   [Full Text] [Related]  

  • 38. Re-establishing immunological self-tolerance in autoimmune disease.
    Sakaguchi S; Powrie F; Ransohoff RM
    Nat Med; 2012 Jan; 18(1):54-8. PubMed ID: 22227673
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune cell signaling in autoimmune diseases.
    Tsokos GC; Rose NR
    Clin Immunol; 2017 Aug; 181():1-8. PubMed ID: 28531376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathology of uveitis.
    Chan CC
    Yan Ke Xue Bao; 1985 Dec; 1(2):133-5. PubMed ID: 2975999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.